INTENSITY THERAPEUTICS, INC.

Intensity Therapeutics, Inc.

Biotechnology • Healthcare • Shelton, CT, United States • INTS (NCM)

Intensity Therapeutics, Inc., a late-stage clinical biotechnology company, engages in the provision of treatment for the regional and systemic nature of cancer in the United States. Its lead product candidate includes INT230-6, which is in Phase 3 clinical studies for the treatment of soft tissue sarcoma; and neoadjuvant and metastatic triple negative breast cancer which is in Phase 2 clinical trials. The company was incorporated in 2012 and is headquartered in Shelton, Connecticut.

203 221 7381 1 Enterprise Drive, Shelton, CT 06484-4779, United States

Stock Performance (90 Days)

Data through Dec 26, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Intensity Therapeutics, Inc. Announces Pricing of $4 Million Registered Direct Offering of Common Stock - PR Newswire
PR Newswire • Oct 31
Intensity Therapeutics stock up nearly 400% on solid tumour data - Clinical Trials Arena
Clinical Trials Arena • Oct 31
All You Need to Know About Intensity Therapeutics Inc. (INTS) Rating Upgrade to Buy - Yahoo Finance
Yahoo Finance • Dec 15
Intensity Therapeutics (Nasdaq: INTS) to present TNBC safety, Phase 3 design at SABCS - Stock Titan
Stock Titan • Dec 11
Intensity Therapeutics stock tumbles after pricing $4 million offering - Investing.com
Investing.com • Oct 31

Other Biotechnology Companies

View All →
CODEXIS, INC. logo Codexis, Inc.
1 layoff tracked
$144.5M market cap
VERTEX PHARMACEUTICALS INC / MA logo Vertex Pharmaceuticals Inc. / MA
$118.68B market cap
REGENERON PHARMACEUTICALS, INC. logo Regeneron Pharmaceuticals, Inc.
$82.72B market cap
ALNYLAM PHARMACEUTICALS, INC. logo Alnylam Pharmaceuticals, Inc.
$52.92B market cap
ARGENX SE logo Argenx SE
$52.62B market cap
INSMED Inc logo Insmed Inc.
$37.61B market cap

Frequently Asked Questions

Has INTENSITY THERAPEUTICS, INC. had layoffs?
No layoff events have been recorded for INTENSITY THERAPEUTICS, INC. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does INTENSITY THERAPEUTICS, INC. have?
INTENSITY THERAPEUTICS, INC. has approximately 5 employees.
What industry is INTENSITY THERAPEUTICS, INC. in?
INTENSITY THERAPEUTICS, INC. operates in the Biotechnology industry, within the Healthcare sector.
Is INTENSITY THERAPEUTICS, INC. a publicly traded company?
Yes, INTENSITY THERAPEUTICS, INC. is publicly traded under the ticker symbol INTS on the NCM. The company has a market capitalization of approximately $0.02 billion.
Where is INTENSITY THERAPEUTICS, INC. headquartered?
INTENSITY THERAPEUTICS, INC. is headquartered in Shelton, CT, United States at 1 Enterprise Drive, Shelton, CT 06484-4779, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.